PUBLIC COMPANY
saveMarinus Pharmaceuticals Inc
updated 2mo ago
community read0 votes
pipeline
1
marketed
1
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Marketed
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase3Open-label Study of Adjunctive GNX Treatment in Children and Adults With TSC-related Epilepsy
- phase3Adjunctive GNX Treatment Compared With Placebo in Children and Adults With TSC-related Epilepsy
- phase3Randomized Therapy In Status Epilepticus
- phase2Open-label Extension to Protocol 1042-0500
- phase3To Evaluate the Efficacy, Safety, and Tolerability of Intravenous Ganaxolone Added to Standard of Care in Refractory Status Epilepticus (RSE)
- phase2Safety and Efficacy Study of IV Ganaxolone as Adjuvant Therapy for Established Status Epilepticus (ESE)
- —Ganaxolone Expanded Access Program Compassionate Use
- phase2A Clinical Trial of Oral Ganaxolone in Women With Postpartum Depression
🐶 Hiring Signal
News
no news has mentioned this company yet
comments(0)
5-min edit window · permanent after that